Oral targeted drug shows encouraging activity in patients with relapsed or resistant AML

Share this content:
Oral targeted drug shows encouraging activity in patients with relapsed or resistant AML
Oral targeted drug shows encouraging activity in patients with relapsed or resistant AML
An oral targeted drug has shown encouraging activity and tolerable side effects in patients with treatment-resistant or relapsed acute myelogenous leukemia (AML) - a poor-prognosis group with few options - report investigators from Dana-Farber Cancer Institute and M.D. Of 32 patients treated ...
READ FULL ARTICLE From News Medical
Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


is free, fast, and customized just for you!

Already a member?

Sign In Now »